Cationic Oil-in-Water Emulsions for RNA Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current nucleic acid delivery systems face challenges in efficiently delivering RNA molecules in vivo due to rapid degradation by nucleases and toxicity issues, and existing nucleic acid-based vaccines require large doses to induce immune responses, with concerns about safety and integration into the host genome.
Innovation Solution
Development of cationic oil-in-water emulsions with an oil core and cationic lipid, where the RNA molecule is complexed to the emulsion particles, achieving an N/P ratio of at least 4:1, to enhance immune response and stability, while avoiding integration into the host genome.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of stationary object
If chemical modifications are used to increase RNA stability, then the half-life of injected RNA is extended, but cytotoxic effects increase or function is lost/decreased
Solution Approach 1:
The patent uses cationic liposomes as intermediary carriers to deliver unmodified RNA molecules into cells. The liposomes protect the RNA from nucleases in the extracellular environment without requiring chemical modifications to the RNA itself, thus extending half-life while avoiding cytotoxicity associated with modified nucleotides
Solution Approach 2:
The patent replaces chemical modification approaches with a physical delivery system (liposomal encapsulation). Instead of chemically altering the RNA to improve stability, the system uses the physical protective barrier of liposomes and the mechanical process of endocytosis to achieve stable delivery and extended RNA half-life
2Reliability
If large doses of nucleic acid are used to obtain potent immune responses, then immune response potency increases, but safety concerns and toxicity increase
Solution Approach 1:
The patent changes the physical parameters of the delivery system (liposome composition, size, charge) to optimize RNA delivery efficiency. By adjusting these parameters, the system achieves potent immune responses at lower RNA doses, reducing toxicity while maintaining reliability
Solution Approach 2:
The patent uses composite liposomal formulations containing cationic lipids mixed with neutral or anionic lipids. This composite structure enhances delivery efficiency and immunogenicity, allowing lower doses of nucleic acid to achieve potent immune responses with reduced toxicity
3Productivity
If cationic liposomes are used to deliver DNA molecules, then transfection efficiency increases, but serum dramatically reduces transfection activity
Solution Approach 1:
The patent modifies the physical and chemical parameters of the liposome system, including lipid composition, particle size, and surface charge density. These parameter changes create liposomes that remain stable and maintain transfection efficiency in the presence of serum, overcoming the limitation of conventional cationic liposomes
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The cationic oil-in-water emulsions effectively deliver RNA molecules, inducing a strong immune response with reduced toxicity and minimizing the risk of genomic integration, providing a stable and potent vaccine delivery method.
Implementation Method 1
The cationic lipid can interact with the negatively charged molecule thereby anchoring the molecule to the emulsion particles
Implementation Method 2
cationic oil-in-water emulsions with an oil core and cationic lipid
Data Source
AI summary
This invention generally relates to cationic oil-in-water emulsions that can be used to deliver nucleic acid molecules, such as an RNA molecule. The emulsion particles comprise an oil core and a cationic lipid. The emulsion particles have an average diameter of about 80 nm to about 180 nm, and the emulsion have an N/P ratio of at least 1.1:1.